The field of localized controlled drug delivery concepts, now affects millions of patients around the world, since its conception in the mid-1960s, wherein it was shown that a Silicone capsule with constant dimension had the potential to deliver a drug at a constant rate . This approach to drug administration has become favorable, as it addresses some of the limitations of the conventional delivery method, such as poor biodistribution, lack of selectivity, toxicity, and even sometimes poor patient compliance, etc., An increasing need for orthopedic implant applications has driven up patient-care and end user needs. In light of this, recent considerations towards the integration of drugeluting implant surfaces have reportedly enhanced the fixation of the implant . This strategy of fab- ricating drug-eluting surfaces on fixed implants has seen an evolution from the conventionally employed drug delivery methodologies using macroscopic delivery devices like mucosal inserts, bandages, and ingestible capsules to subsequent progressions in the 1990s when microscopic degradable polymers were commercialized to the currently active trend of integrating nanotechnology into drug delivery ].